B.A., Chemistry, DePauw University, Greencastle IN
M.D., University of Illinois College of Medicine, Chicago IL
Internship, Medicine, Lutheran General Hospital, Park Ridge IL
Residency, Internal Medicine, Lutheran General Hospital, Park Ridge IL
Fellowship, Rheumatology, Duke University Medical Center, Durham NC
Masters in Health Sciences, Biometry, Duke University School of Medicine, Durham NC
Fellow, American College of Physicians
Fellow, American College of Rheumatology
American College of Rheumatology Scholar Award
American College of Rheumatology Traveling Student Award
University of Chicago Distinguished Resident Teaching Award
Bello AE, Garrett WE, Wang H, Lohnes J, DeLong E, Caterson B, Kraus VB. Comparison of synovial fluid cartilage concentrations and chondral damage assessed arthroscopically in acute knee injury. Osteoarthritis Cartilage 1997;5:419-426.
Patterson R, Bello AE, Lefkowith J. Immunologic tolerability profile of celecoxib. Clin Therapeutics 1999; 21(12):2065-2077.
Welton A, Fort JG, Puma JA, Normandin D, Bello AE, Verburg KM. Cyclooxygenase-2-specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Therapeutics 2001;8:85-96.
McKenna F, Weaver A, Fiechtner JJ, Bello AE, Fort JG. COX-2 specific inhibitors in the management of osteoarthritis: a placebo-controlled, randomized, double-blind study. J Clin Rheum 2001:7;151-9.
Whelton A, White WB, Bello AE, Puma JA, Fort JG. Effects of celecoxib and rofecoxib on blood pressure and edema in patients >/=65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol 2002 Nov 1;90(9):959-63.
Whelton A, Fort JG, Puma JA, Normandin D, Bello AE, Verburg KM. Cyclooxygenase-2-specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Manag Care 2002 Oct;8(15 Suppl):S371-82.
Goldstein JL, Bello AE, Spalding W, Suh S, Fort JG. Cyclooxygenase-2 specific inhibitors and upper gastrointestinal tolerability in patients with osteoarthritis receiving concomitant low dose aspirin: pooled analysis of 2 trials. J Rheumatol. 2005 Jan;32(1):111-7
Singh G, Fort J, Goldstein J, Levy R, Hanrahan P, Bello A, et. al. Efficacy and upper gastrointestinal safety of celecoxib compared to naproxen and diclofenac in patients with osteoarthritis: randomized, double blind, controlled, multicenter, multinational trial (the SUCCESS-I study). Am J Medical 2006 Mar;119(3):255-66
Bello AE, Oesser S. Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature. Curr Med Res Opin 2006; 22(11): 2221–2232.
Clinical Associate Professor of Medicine,University of Illinois College of Medicine, Chicago IL
Adjunct Associate Professor of Family Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL
Consulting Associate, Duke University Medical Center, Division of Rheumatology, Allergy and Clinical Immunology, Durham NC
Director of Clinical Research, IBJI Rheumatology
Former Chief, Section of Rheumatology, Department of Internal Medicine, Advocate Illinois Masonic Medical Center, Chicago IL
Chief Medical Officer, Integrated Medical Affairs, Inc., Glenview IL